Incidence of herpes zoster in patients with giant cell arteritis: A population-based cohort study

Valentin S. Schäfer, Tanaz A. Kermani, Cynthia Crowson, Gene G. Hunder, Sherine E. Gabriel, Steven R Ytterberg, Eric Lawrence Matteson, Kenneth J Warrington

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objectives: To determine the incidence of herpes zoster (HZ) in GCA. Methods: Utilizing the resources of the Rochester Epidemiology Project, all incident cases of GCA diagnosed between 1 January 1950 and 31 December 2004 were identified. For each GCA patient, two subjects without GCA of the same gender and similar age and length of medical history were randomly selected from the population. Patients were followed until death, last contact or 31 December 2006. Results: The study population included 204 GCA patients and 407 non-GCA subjects. The GCA cohort had 163 (79%) women and 41 (21%) men, with a mean age of 76.0 (8.2) years. The non-GCA cohort had 325 (80%) women and 82 (20%) men, with a mean age of 75.6 (8.4) years. During follow-up, 21 GCA patients and 38 non-GCA subjects developed HZ. There was no difference in the development of HZ in GCA patients compared with non-GCA patients [hazard ratio (HR): 1.22; 95% CI 0.71, 2.08; adjusted for age, sex and calendar year]. No GCA patient and one non-GCA subject developed HZ within 6 months of index date. The frequency of post-herpetic neuralgia was similar between both groups (P=0.64). Conclusions: Patients with GCA do not appear to be at increased risk of HZ compared with the general population, even during the first 6 months of therapy when glucocorticoid doses are usually highest.

Original languageEnglish (US)
Article numberkeq200
Pages (from-to)2104-2108
Number of pages5
JournalRheumatology
Volume49
Issue number11
DOIs
StatePublished - Jul 13 2010

Fingerprint

Giant Cell Arteritis
Herpes Zoster
Cohort Studies
Incidence
Population
Neuralgia
Glucocorticoids
Epidemiology

Keywords

  • Giant cell arteritis
  • Glucocorticoids
  • Herpes zoster

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Incidence of herpes zoster in patients with giant cell arteritis : A population-based cohort study. / Schäfer, Valentin S.; Kermani, Tanaz A.; Crowson, Cynthia; Hunder, Gene G.; Gabriel, Sherine E.; Ytterberg, Steven R; Matteson, Eric Lawrence; Warrington, Kenneth J.

In: Rheumatology, Vol. 49, No. 11, keq200, 13.07.2010, p. 2104-2108.

Research output: Contribution to journalArticle

@article{ac17a769cdb245a8951608aea8fcf6af,
title = "Incidence of herpes zoster in patients with giant cell arteritis: A population-based cohort study",
abstract = "Objectives: To determine the incidence of herpes zoster (HZ) in GCA. Methods: Utilizing the resources of the Rochester Epidemiology Project, all incident cases of GCA diagnosed between 1 January 1950 and 31 December 2004 were identified. For each GCA patient, two subjects without GCA of the same gender and similar age and length of medical history were randomly selected from the population. Patients were followed until death, last contact or 31 December 2006. Results: The study population included 204 GCA patients and 407 non-GCA subjects. The GCA cohort had 163 (79{\%}) women and 41 (21{\%}) men, with a mean age of 76.0 (8.2) years. The non-GCA cohort had 325 (80{\%}) women and 82 (20{\%}) men, with a mean age of 75.6 (8.4) years. During follow-up, 21 GCA patients and 38 non-GCA subjects developed HZ. There was no difference in the development of HZ in GCA patients compared with non-GCA patients [hazard ratio (HR): 1.22; 95{\%} CI 0.71, 2.08; adjusted for age, sex and calendar year]. No GCA patient and one non-GCA subject developed HZ within 6 months of index date. The frequency of post-herpetic neuralgia was similar between both groups (P=0.64). Conclusions: Patients with GCA do not appear to be at increased risk of HZ compared with the general population, even during the first 6 months of therapy when glucocorticoid doses are usually highest.",
keywords = "Giant cell arteritis, Glucocorticoids, Herpes zoster",
author = "Sch{\"a}fer, {Valentin S.} and Kermani, {Tanaz A.} and Cynthia Crowson and Hunder, {Gene G.} and Gabriel, {Sherine E.} and Ytterberg, {Steven R} and Matteson, {Eric Lawrence} and Warrington, {Kenneth J}",
year = "2010",
month = "7",
day = "13",
doi = "10.1093/rheumatology/keq200",
language = "English (US)",
volume = "49",
pages = "2104--2108",
journal = "Rheumatology (United Kingdom)",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Incidence of herpes zoster in patients with giant cell arteritis

T2 - A population-based cohort study

AU - Schäfer, Valentin S.

AU - Kermani, Tanaz A.

AU - Crowson, Cynthia

AU - Hunder, Gene G.

AU - Gabriel, Sherine E.

AU - Ytterberg, Steven R

AU - Matteson, Eric Lawrence

AU - Warrington, Kenneth J

PY - 2010/7/13

Y1 - 2010/7/13

N2 - Objectives: To determine the incidence of herpes zoster (HZ) in GCA. Methods: Utilizing the resources of the Rochester Epidemiology Project, all incident cases of GCA diagnosed between 1 January 1950 and 31 December 2004 were identified. For each GCA patient, two subjects without GCA of the same gender and similar age and length of medical history were randomly selected from the population. Patients were followed until death, last contact or 31 December 2006. Results: The study population included 204 GCA patients and 407 non-GCA subjects. The GCA cohort had 163 (79%) women and 41 (21%) men, with a mean age of 76.0 (8.2) years. The non-GCA cohort had 325 (80%) women and 82 (20%) men, with a mean age of 75.6 (8.4) years. During follow-up, 21 GCA patients and 38 non-GCA subjects developed HZ. There was no difference in the development of HZ in GCA patients compared with non-GCA patients [hazard ratio (HR): 1.22; 95% CI 0.71, 2.08; adjusted for age, sex and calendar year]. No GCA patient and one non-GCA subject developed HZ within 6 months of index date. The frequency of post-herpetic neuralgia was similar between both groups (P=0.64). Conclusions: Patients with GCA do not appear to be at increased risk of HZ compared with the general population, even during the first 6 months of therapy when glucocorticoid doses are usually highest.

AB - Objectives: To determine the incidence of herpes zoster (HZ) in GCA. Methods: Utilizing the resources of the Rochester Epidemiology Project, all incident cases of GCA diagnosed between 1 January 1950 and 31 December 2004 were identified. For each GCA patient, two subjects without GCA of the same gender and similar age and length of medical history were randomly selected from the population. Patients were followed until death, last contact or 31 December 2006. Results: The study population included 204 GCA patients and 407 non-GCA subjects. The GCA cohort had 163 (79%) women and 41 (21%) men, with a mean age of 76.0 (8.2) years. The non-GCA cohort had 325 (80%) women and 82 (20%) men, with a mean age of 75.6 (8.4) years. During follow-up, 21 GCA patients and 38 non-GCA subjects developed HZ. There was no difference in the development of HZ in GCA patients compared with non-GCA patients [hazard ratio (HR): 1.22; 95% CI 0.71, 2.08; adjusted for age, sex and calendar year]. No GCA patient and one non-GCA subject developed HZ within 6 months of index date. The frequency of post-herpetic neuralgia was similar between both groups (P=0.64). Conclusions: Patients with GCA do not appear to be at increased risk of HZ compared with the general population, even during the first 6 months of therapy when glucocorticoid doses are usually highest.

KW - Giant cell arteritis

KW - Glucocorticoids

KW - Herpes zoster

UR - http://www.scopus.com/inward/record.url?scp=78649336730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649336730&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keq200

DO - 10.1093/rheumatology/keq200

M3 - Article

C2 - 20627970

AN - SCOPUS:78649336730

VL - 49

SP - 2104

EP - 2108

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

SN - 1462-0324

IS - 11

M1 - keq200

ER -